GovWire

This document sets out theNHSs quarterly aggregate net sales and payment information on pharmaceuticals for September 2024 .

The2024 voluntary scheme for branded medicines pricing, access and growth(VPAG)is an agreement between the Department for Health and Social Care,NHSEngland and the Association of the British Pharmaceutical Industry that aims to:

• promote better patient outcomes and a healthier population
• support UK economic growth
• contribute to a financially sustainable NHS